Abstract

Transition metals, such as zinc, are essential micronutrients in all organisms, but also highly toxic in excessive amounts. Heavy-metal transporting P-type (PIB) ATPases are crucial for homeostasis, conferring cellular detoxification and redistribution through transport of these ions across cellular membranes. No structural information is available for the PIB-4-ATPases, the subclass with the broadest cargo scope, and hence even their topology remains elusive. Here we present structures and complementary functional analyses of an archetypal PIB‑4‑ATPase, sCoaT from Sulfitobacter sp. NAS14-1. The data disclose the architecture, devoid of classical so-called heavy metal binding domains, and provides fundamentally new insights into the mechanism and diversity of heavy-metal transporters. We reveal several novel P-type ATPase features, including a dual role in heavy-metal release and as an internal counter ion of an invariant histidine. We also establish that the turn-over of PIB‑ATPases is potassium independent, contrasting to many other P-type ATPases. Combined with new inhibitory compounds, our results open up for efforts in e.g. drug discovery, since PIB-4-ATPases function as virulence factors in many pathogens.

Data availability

Atomic coordinates and structure factors for the sCoaT AlF4-- and BeF3--stabilized crystal structures have been deposited at the Protein Data Bank (PDB) under accession codes 7QBZ and 7QC0.

The following data sets were generated

Article and author information

Author details

  1. Christina Grønberg

    Department of Biomedical Sciences, University of Copenhagen, Copenhagen N, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  2. Qiaoxia Hu

    Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  3. Dhani Ram Mahato

    Department of Chemistry, Umeå University, Umeå, Sweden
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1121-7761
  4. Elena Longhin

    Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  5. Nina Salustros

    Department of Biomedical Sciences, University of Copenhagen, Copenhagen N, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  6. Annette Duelli

    Department of Biomedical Sciences, University of Copenhagen, Copenhagen N, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  7. Pin Lyu

    Department of Biomedical Sciences, University of Copenhagen, Copenhagen N, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  8. Viktoria Bågenholm

    Department of Biomedical Sciences, University of Copenhagen, Copenhagen N, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  9. Jonas Eriksson

    Department of Chemistry, Umeå University, Umeå, Sweden
    Competing interests
    The authors declare that no competing interests exist.
  10. Komal Umashankar Rao

    Department of Laboratory Medicine, Lund University, Lund, Sweden
    Competing interests
    The authors declare that no competing interests exist.
  11. Domhnall Iain Henderson

    Department of Laboratory Medicine, Lund University, Lund, Sweden
    Competing interests
    The authors declare that no competing interests exist.
  12. Gabriele Meloni

    Department of Chemistry and Biochemistry, The University of Texas at Dallas, Richardson, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4976-1401
  13. Magnus Andersson

    Department of Chemistry, Umeå University, Umeå, Sweden
    Competing interests
    The authors declare that no competing interests exist.
  14. Tristan Croll

    Department of Haematology, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  15. Gabriela Godaly

    Department of Laboratory Medicine, Umeå University, Umeå, Sweden
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3467-1350
  16. Kaituo Wang

    Department of Biomedical Sciences, University of Copenhagen, Copenhagen N, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  17. Pontus Gourdon

    Department of Biomedical Sciences, University of Copenhagen, Copenhagen N, Denmark
    For correspondence
    pontus@sund.ku.dk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8631-3539

Funding

Novo Nordisk Fonden (NNF18SA0034956)

  • Christina Grønberg

Lundbeckfonden (R313-2019-774,R218-2016-1548,R133-A12689)

  • Pontus Gourdon

Knut och Alice Wallenbergs Stiftelse (2020.0194,2015.0131)

  • Pontus Gourdon

Carlsbergfondet (CF15-0542,2013_01_0641)

  • Pontus Gourdon

Novo Nordisk Fonden (NNF13OC0007471)

  • Pontus Gourdon

Brodrene Hartmann (A29519)

  • Pontus Gourdon

Agnes og Poul Friis Fond

  • Pontus Gourdon

Augustinus Fonden (16-1992)

  • Pontus Gourdon

Crafoord (20180652,20170818)

  • Pontus Gourdon

Per-Eric and Ulla Schyberg (38267)

  • Pontus Gourdon

Swedish Research Council (2016-04474)

  • Pontus Gourdon

The memorial foundation of manufacturer Vilhelm Pedersen and wife - and the Aarhus Wilson consortium

  • Christina Grønberg

The Independent Research Fund Denmark (9039-00273A)

  • Pontus Gourdon

China Scholarship Council

  • Qiaoxia Hu

Carl Tryggers Stiftelse för Vetenskaplig Forskning (CTS 17:22)

  • Dhani Ram Mahato

Swedish Research Council Starting Grant (2016-03610)

  • Magnus Andersson

Robert A. Welke Cancer Research Foundation (AT-1935-20170325 and AT-2073-20210327)

  • Gabriele Meloni

National Institute of General Medical Sciences (R35GM128704))

  • Gabriele Meloni

National Science Foundation (CHE- 2045984)

  • Gabriele Meloni

Swedish Heart-Lung Foundation (20200378)

  • Gabriela Godaly

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Merritt Maduke, Stanford University School of Medicine, United States

Version history

  1. Received: August 17, 2021
  2. Preprint posted: September 5, 2021 (view preprint)
  3. Accepted: December 17, 2021
  4. Accepted Manuscript published: December 24, 2021 (version 1)
  5. Version of Record published: February 25, 2022 (version 2)

Copyright

© 2021, Grønberg et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,438
    Page views
  • 251
    Downloads
  • 6
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Christina Grønberg
  2. Qiaoxia Hu
  3. Dhani Ram Mahato
  4. Elena Longhin
  5. Nina Salustros
  6. Annette Duelli
  7. Pin Lyu
  8. Viktoria Bågenholm
  9. Jonas Eriksson
  10. Komal Umashankar Rao
  11. Domhnall Iain Henderson
  12. Gabriele Meloni
  13. Magnus Andersson
  14. Tristan Croll
  15. Gabriela Godaly
  16. Kaituo Wang
  17. Pontus Gourdon
(2021)
Structure and ion-release mechanism of PIB-4-type ATPases
eLife 10:e73124.
https://doi.org/10.7554/eLife.73124

Share this article

https://doi.org/10.7554/eLife.73124

Further reading

    1. Biochemistry and Chemical Biology
    Jake W Anderson, David Vaisar ... Natalie G Ahn
    Research Article

    Activation of the extracellular signal-regulated kinase-2 (ERK2) by phosphorylation has been shown to involve changes in protein dynamics, as determined by hydrogen-deuterium exchange mass spectrometry (HDX-MS) and NMR relaxation dispersion measurements. These can be described by a global exchange between two conformational states of the active kinase, named ‘L’ and ‘R,’ where R is associated with a catalytically productive ATP-binding mode. An ATP-competitive ERK1/2 inhibitor, Vertex-11e, has properties of conformation selection for the R-state, revealing movements of the activation loop that are allosterically coupled to the kinase active site. However, the features of inhibitors important for R-state selection are unknown. Here, we survey a panel of ATP-competitive ERK inhibitors using HDX-MS and NMR and identify 14 new molecules with properties of R-state selection. They reveal effects propagated to distal regions in the P+1 and helix αF segments surrounding the activation loop, as well as helix αL16. Crystal structures of inhibitor complexes with ERK2 reveal systematic shifts in the Gly loop and helix αC, mediated by a Tyr-Tyr ring stacking interaction and the conserved Lys-Glu salt bridge. The findings suggest a model for the R-state involving small movements in the N-lobe that promote compactness within the kinase active site and alter mobility surrounding the activation loop. Such properties of conformation selection might be exploited to modulate the protein docking interface used by ERK substrates and effectors.

    1. Biochemistry and Chemical Biology
    Anne E Hultgren, Nicole MF Patras, Jenna Hicks
    Feature Article

    Organizations that fund research are keen to ensure that their grant selection processes are fair and equitable for all applicants. In 2020, the Arnold and Mabel Beckman Foundation introduced blinding to the first stage of the process used to review applications for Beckman Young Investigator (BYI) awards: applicants were instructed to blind the technical proposal in their initial Letter of Intent by omitting their name, gender, gender-identifying pronouns, and institutional information. Here we examine the impact of this change by comparing the data on gender and institutional prestige of the applicants in the first four years of the new policy (BYI award years 2021–2024) with data on the last four years of the old policy (2017–2020). We find that under the new policy, the distribution of applicants invited to submit a full application shifted from those affiliated with institutions regarded as more prestigious to those outside of this group, and that this trend continued through to the final program awards. We did not find evidence of a shift in the distribution of applicants with respect to gender.